Live news: Japan will expand the state of emergency; Disposal in New Zealand due to a possible stabbing error with saline “regret” World news


0

Moderna has completed an application for full regulatory approval of its Covid-19 vaccine in people over the age of 18, the company said.

Reuters reports that U.S. health officials expect full approval for the Covid-19 vaccine to win over skeptics of the vaccine and encourage more state and local governments, as well as private employers, to impose mandates for the killings.

But experts warned that the accelerated general authority Pfizer’s apple this week was made behind closed doors based on six months’ worth of data from 12,000 people – a rare case of a vaccine for mass use that could “set a precedent for lowered standards for future vaccine approvals.”

The Pfizer-BioNTech sting was developed with the same mRNA technology as Modern, which encourages the human body to make a protein that is part of the Covid pathogen, eliciting an immune response.

Reuters reports that the completed submission of Moderna includes data from a late-stage study that showed 93% effectiveness of the vaccine within six months of the second dose, the company said in a statement.

As part of the submission, Moderna requested a priority review of its vaccine, currently available in the U.S. for people over the age of 18 under an Emergency Authorization (EUA) issued by the Food and Drug Administration in December.

So far, the company has released more than 300 million doses of the vaccine to the U.S. government, but it is not clear how many have been administered.

The British Medical Journal said this week that Pfizer-BioNTech released updated results for its Phase 3 trial on July 28, but without new data and with the same efficacy score at the top as the previous preprint — after admitting its effectiveness was significantly reduced it is used to justify calls for reinforcements.

There are also concerns that pharmaceutical companies have allowed all trial participants to be formally deanonymized for researchers starting in December last year, and placebo recipients to be vaccinated, after receiving emergency approval.

By March 13, 93% of respondents were blind, officially entering “open monitoring”, so the reprint of the company’s data was based on 7% of survey participants who remained anonymous after six months.

.


Like it? Share with your friends!

0

What's Your Reaction?

hate hate
0
hate
confused confused
0
confused
fail fail
0
fail
fun fun
0
fun
geeky geeky
0
geeky
love love
0
love
lol lol
0
lol
omg omg
0
omg
win win
0
win
Stacy

0 Comments

Your email address will not be published. Required fields are marked *